ProQR Therapeutics N.V. announced that John Maraganore has joined ProQR as a strategic advisor. Dr. John Maraganore served as the founding CEO and a Director of Alnylam from 2002 to 2021. He continues to serve on the Alnylam Scientific Advisory Board. Prior to Alnylam, he served as an officer and a member of the management team for Millennium Pharmaceuticals Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | +5.98% | +3.72% | -1.52% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.52% | 16Cr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.03% | 2.2TCr | |
-8.05% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr | |
+77.64% | 887.31Cr |
- Stock Market
- Equities
- PRQR Stock
- News ProQR Therapeutics N.V.
- ProQR Therapeutics N.V. Appoints John Maraganore as Strategic Advisor to the Supervisory Board